Josefin Snellman
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Physician and Patient Perception of Disease, Symptomatology, and Treatment Administration Preference in Paroxysmal Nocturnal Haemoglobinuria: Results from a Real-World Survey.
Journal: Advances in therapy
Published: April 14, 2026
Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment.
Journal: Journal of comparative effectiveness research
Published: March 19, 2026
Impact of Erenumab on Comorbid Depression, Anxiety, and Sleep Quality in Migraine: A Registry for Migraine (REFORM) Study.
Journal: European journal of neurology
Published: July 28, 2025
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab.
Journal: Cephalalgia : an international journal of headache
Published: June 11, 2024
Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation.
Journal: Cephalalgia : an international journal of headache
Published: June 08, 2024
Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial.
Journal: Cephalalgia : an international journal of headache
Published: January 05, 2024
Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study.
Journal: Headache
Published: December 22, 2023
Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab.
Journal: British journal of pharmacology
Published: May 19, 2023
Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans.
Journal: Brain : a journal of neurology
Published: March 12, 2023
Last Updated: 09/26/2026